Purpose of review Extracellular vesicles have emerged as one of the most important means through which cells interact with each other and the extracellular environment, but extracellular vesicle research remains challenging due to their small size, limited amount of material required for traditional molecular biology assays and inconsistency in the methods of their isolation. The advent of new technologies and standards in the field, however, have led to increased mechanistic insight into extracellular vesicle function. Herein, the latest studies on the role of extracellular vesicles in cardiovascular physiology and disease are discussed. 
INTRODUCTION
Vesicles secreted from cells into the extracellular space (extracellular vesicles) play an increasingly recognized role in both physiological and pathological processes. Once thought to serve solely as a mechanism to remove waste material from cells, studies conducted over the past two decades have demonstrated that extracellular vesicles allow cells to interact with their neighbours and the extracellular environment. Extracellular vesicles contain genetic (RNA and DNA) and proteomic material. Importantly, although the proteins and genetic material may reflect properties of the parent cells, extracellular vesicles are generally not mirror images of the cellular membrane. This suggests that extracellular vesicles are derived from specific subcellular locations, and the contents are likely intended for a defined function in the extracellular space.
Due to their small size, however, difficulties remain in characterizing the myriad of extracellular vesicles released by cells. At any given time, cells may shed extracellular vesicles through direct budding at the plasma membrane or through a variety of intracellular trafficking pathways that result in fusion of multivesicular bodies to the membrane and subsequent expulsion of intraluminal vesicles (Fig. 1) . Multivesicular bodies form within cells following invagination of plasma membrane in endocytotic vesicles. As these recycling endosomes traffic through the cell cytoplasm, new vesicles form through invagination of small vesicles into the intraluminal space of the larger endosome. The resultant extracellular vesicles released by membrane fusion of the endosome are usually termed exosomes. Extracellular vesicles that bud from the membrane require coordinated cytoskeletal dynamics that lead to plasma membrane protrusion, and actin-mediated constriction that separates the membrane and releases the extracellular vesicle into the extracellular space. These extracellular vesicles are often termed microvesicles or microparticles, and generally have a larger average diameter than extracellular vesicles produced through intracellular trafficking. These canonical mechanisms of extracellular vesicle formation, however, may not capture all forms of extracellular vesicle genesis, namely those derived from intracellular organelles.
The lack of reliable methods to separate extracellular vesicle populations postrelease leads to confusion surrounding overlap in extracellular vesicle functions across numerous studies. Investigators often use specific names to describe the function or properties of the extracellular vesicle populations of interest (e.g. calcifying matrix vesicles, tolerosomes, prostasomes), but it is unclear whether these different functions belong to the same extracellular vesicles or different populations of extracellular vesicles. Even more general terms such as microvesicles, microparticles and exosomes have overlapping characteristics (e.g. size ranges, sedimentation properties, proteomic markers). Therefore, studies often use a combination of factors such as extracellular vesicle size and known protein markers to verify the presence of specific extracellular vesicle populations. Although different extracellular vesicle populations may contain different membrane lipid profiles, membrane-associated proteins and intraluminal genetic material and proteins, the relative abundance of these factors per extracellular vesicle is relatively small and difficult to assay.
Barriers remain in characterizing extracellular vesicles, but new technologies such as tunable
KEY POINTS
Cells rely on extracellular vesicles to interact with the extracellular environment.
Extracellular vesicles mediate communication between cells in the same tissue and by carrying messages through circulation to distant tissues.
Extracellular matrix formation and remodelling often relies on the presence of specific enzymes on and within extracellular vesicles.
Delivery of extracellular vesicles from cultured stem cell populations can protect and regenerate diseased cardiovascular tissues.
Controlling and/or mimicking extracellular vesicle function can serve as a powerful therapeutic strategy for cardiovascular diseases. ]. Poor signal-to-noise ratios remain a problem in these measurements, limiting its ability to identify low abundance proteins. The development of new methods to measure extracellular vesicle properties and their subcellular origins will likely lead to desired mechanistic insight. Excellent reviews have focused on the fingerprinting and functional characterization of various extracellular vesicle populations. To broadly characterize the role of extracellular vesicles in cardiovascular homeostasis and disease, we will discuss extracellular vesicle function within two larger contexts: extracellular vesicles as mediators of intracellular communication and extracellular vesicles as mediators of extracellular matrix (ECM) remodelling. The reader should note, however, that in some cases these functions could belong to the same extracellular vesicles. Finally, we will briefly review efforts to harness extracellular vesicle properties for diagnostic and therapeutic purposes.
EXTRACELLULAR VESICLES AS MEDIATORS OF INTRACELLULAR COMMUNICATION
The ability to serve as vehicles of intercellular communication is one of the most well studied functions of extracellular vesicles; however, due to the myriad of extracellular vesicle subtypes and equally diverse set of cargo, the mechanisms by which messages are selectively delivered from source cells to target cells remain the subject of ongoing research. In accordance with previous observations with synthetic nanoparticles used for intracellular delivery, extracellular vesicle size plays an important role in the ability to transfer material (e.g. RNA or proteins) into a target cell. Relatively smaller extracellular vesicles (30-50 nm) tend to exhibit higher uptake in target cells and consequently induce larger phenotypic responses [4] . Changes in the extracellular environment can influence both extracellular vesicle physical properties and cargo. Elevated glucose to diabetic levels induces an increase in both the rate of extracellular vesicle release and the size of extracellular vesicles produced by endothelial cells in culture [5] . Circulating endothelial-derived extracellular vesicles in patients with cerebrovascular atherosclerosis exhibit altered protein expression consistent with known changes in endothelial cell phenotype [6] , and vascular smooth muscle cells (VSMCs) exposed to atherogenic lipoproteins exhibit altered extracellular vesicle microRNA profiles [7 && ]. These changes in extracellular vesicle size and/or cargo could alter communication between cells to respond to an extracellular cue and may exacerbate pathological conditions by disrupting homeostatic paracrine signaling.
Extracellular vesicle mediated paracrine signalling can act both locally (i.e. between cells within the same tissue) and distally by travelling with blood to downstream targets (Fig. 2) . Arteriosclerosis, vascular restenosis following catheter-based interventions and outward aneurysmal remodelling involve phenotypic changes in vascular endothelial and smooth muscle cells (SMCs). Accumulating evidence suggests a role for extracellular vesicles in mediating the cellular crosstalk in response to extracellular stimuli that trigger changes in phenotype and the resultant tissue remodelling. Vascular SMC proliferation and migration from the medial space is often an early response to pathological cues. Patients with coronary artery disease exhibit an inverse relationship between percutaneous coronary intervention rate and the expression of micro-RNA-126 in circulating extracellular vesicles [8] . Intravenous injection of endothelial-derived extracellular vesicles loaded with microRNA-126 prevents SMC proliferation, migration and neointima formation in a mouse model of vascular injury. Similarly, platelet-derived extracellular vesicles can induce a pro-inflammatory remodelling phenotype in SMCs, including increased migration and proliferation [9] . Systemic pressures (e.g. introduction of pathological agents) often first effect blood cells and the endothelial cells that line the blood vessel. These studies suggest that extracellular vesicles can mediate communication from these cells to the SMCs located deeper in the tissue. In turn, vascular SMCs directly control tissue homeostasis through synthesis and degradation of ECM components.
Extracellular vesicle mediated signalling, however, is not unidirectional from the blood into the vascular wall. Endoplasmic reticulum stress leads to production of SMC-derived extracellular vesicles, which promote endothelial cell dysfunction in a model of thoracic aortic aneurysm [10] . Classically, endothelial cell dysfunction leads to expression of adhesion proteins that aid in the translocation of leukocytes from the blood into vascular tissue, wherein these cells contribute to vascular wall remodelling. Following acute myocardial infarction, large numbers splenic monocytes mobilize to the damaged myocardium. Recent evidence suggests a role for endothelial-derived extracellular vesicles in the initial monocytic recruitment [11 & ]. The total number of circulating extracellular vesicles increases in plasma following myocardial infarction in both mice and humans, and the elevated number of extracellular vesicles exhibit protein markers that suggest an endothelial cell origin. These extracellular vesicles also contain the same microRNA-126 that modulates VSMC phenotype. Accumulation of these extracellular vesicles in the spleen promotes mobilization of monocytes, which migrate to the infarcted site and aid in tissue repair. Thus, endothelial cell-derived extracellular vesicles containing microRNA-126 can affect tissue homeostasis through both local regulation of vascular SMC phenotype and distal recruitment of leukocytes.
Extracellular vesicles as mediators of interorgan communication has received increased attention due to pioneering cancer research [12] . Extracellular vesicles carry tumorigenic components through systemic circulation and can prime distal sites for metastatic invasion. Recent studies suggest that adipose tissue serves as a source for a large number of circulating extracellular vesicles [13 && ]. Knocking out Dicer, the microRNA processing enzyme, in mouse adipose tissue leads to decreased glucose tolerance. Reintroducing adipose tissue containing Dicer into these mice improves glucose tolerance and decreases circulating levels of insulin and liver-derived fibroblast growth factor-21 (FGF21). These findings show the importance of adipose tissue in regulating gene expression throughout the body and underscore the role of extracellular vesicles in systemic homeostasis.
EXTRACELLULAR VESICLES AS MEDIATORS OF CELL-MATRIX INTERACTIONS
ECM structure determines the biomechanical function of cardiovascular tissues, and inappropriate remodelling contributes to morbidity and mortality. Failure of the collagenous fibrous cap contributes to atherosclerotic plaque rupture, the leading cause of death globally. Typically, plaque vulnerability associates with low collagen content in the fibrous cap, which compromises its tensile strength [14] . Recent computational studies, however, highlight the presence of destabilizing microcalcifications (approximately 5 mm), smaller than the resolution limits of traditional clinical imaging modalities, in the cap of 'vulnerable plaques' as a determinant of their biomechanical failure [15, 16] . Prospective clinical data from the Multi-Ethnic Study of Atherosclerosis (MESA) trial [17] corroborate the biomechanical model predictions linking microcalcifications with plaque rupture. These data indicate that larger calcifications may stabilize atherosclerotic plaques, whereas 'spotty' calcification (or early microcalcificaiton) contributes to plaque destabilization [18] . Although large calcifications may stabilize plaques www.co-cardiology.comin the short-term, continued calcification growth can also induce vessel stenosis, reduced blood flow and elevated systemic resistance [19] . Therefore, calcification morphology correlates with cardiovascular risk.
Calcification comprises extracellular vesicles that serve as nucleating foci for mineralization. Yet, the process by which extracellular vesicles contribute to vascular calcification is difficult to study due to the inability to visualize and monitor early calcification events in vivo. We recently developed a three-dimensional in-vitro platform in which we seeded extracellular vesicles obtained from human vascular SMCs in a collagen hydrogel [20 && ]. This platform allowed us to directly observe the growth of microcalcification from single extracellular vesicles to mature calcifications spectroscopically similar to those observed in human atherosclerotic plaques. Using this platform and analysis of human plaques, we documented an inverse relationship between collagen and microcalcification size. Calcifying extracellular vesicles aggregate and fuse to form microcalcifications, and when unencumbered by collagen, the microcalcifications serve as building blocks for larger calcifications (Fig. 3) .
The formation of calcifying extracellular vesicles begins with phenotypic changes within the parent cells that result in enrichment of promineralizing factors. In valve interstitial cells, elevated extracellular calcium and phosphate induce release of extracellular vesicles enriched with Annexin VI [21 & ]. Similar to its function in vascular SMCs, Annexin VI mediates calcium binding in extracellular vesicles, promoting mineral formation. Conditions that simulate inflammation-induced osteogenic changes in SMCs result in the loading of active tissue nonspecific alkaline phosphatase (TNAP) into extracellular vesicles through intracellular trafficking mechanisms directed by the sorting receptor sortilin [22 & ]. Active TNAP hydrolyzes the calcification inhibitor pyrophosphate and produces free phosphate required for mineralization, promoting mineralization even in normal ranges of extracellular phosphate. Vascular SMC phenotypic changes and resultant production of calcifying extracellular vesicles also depends on feedback from the ECM. Impaired collagen sensing through the collagen receptor discoidin domain receptor-1 (DDR-1) leads to an increase in fibrotic collagen and calcifying extracellular vesicle release from SMCs [23] , suggesting that the extracellular vesicles can serve as a mechanism for delivery of ECM and mineral components to help the vascular SMCs respond to lost extracellular homeostasis. The altered loading and trafficking patterns that result in the formation of calcifying extracellular vesicles offer potential therapeutic targets for cardiovascular calcification and vascular wall remodelling, major contributors to morbidity with no known treatment. Extracellular vesicles also play a significant role in postplaque rupture responses. Immediately following atherosclerotic plaque rupture leads to thrombotic vessel occlusion associated with platelet activation and activation of the coagulation cascade. Progression of the coagulation cascade requires the presence and activation of several enzymes that aid in the generation of thrombin, and many of the rate limiting enzymatic reactions begin at the surface of extracellular vesicles [24] . Tissue factor, a key enzyme that initiates the coagulation cascade, is found on subpopulations of extracellular vesicles derived from vascular SMCs [25 & ], endothelial cells [26] , monocytes/macrophages [27] and platelets [28] . Further, the charged phospholipid profile (e.g. enrichment of phosphatidylserine) characteristic of many extracellular vesicle populations may also aid in the generation of thrombin [28] . In response to the generation of thrombin, local platelets release exosomal extracellular vesicles that mediate paracrine signalling to endothelial cells [29] . In turn, the endothelial cells release extracellular vesicles enriched with matrix metallopreinase-10, which exacerbate the proinflammatory vascular wall remodelling [30] . Acetylsalicylic acid (aspirin) treatment significantly reduces the release of exosomal extracellular vesicles from platelets [29] , perhaps contributing to its function in preventing thrombosis.
EXTRACELLULAR VESICLES AS THERAPEUTIC VEHICLES AND DIAGNOSTIC TOOLS
Circulating extracellular vesicles are often analyzed for their potential to serve as diagnostic tools for a variety of diseases. As extracellular vesicle contents can change in a manner that reflects alterations in cell phenotype, extracellular vesicles in the blood stream can serve as a noninvasive means to measure the phenotypic state of tissues throughout the body. For example, SMCs exposed to atherogenic lipoproteins release extracellular vesicles with significantly altered microRNA profiles, including a decrease in microRNA-24-3p and -130a-3p [7 && ]. Perhaps relatedly, these two microRNAs exhibit decreased expression in circulating extracellular vesicles from individuals with familial hypercholesterolemia. In addition to their diagnostic potential, however, recent studies have shown a tremendous capacity for extracellular vesicles to serve as therapeutic agents and restore tissue homeostasis [31] . Endothelial extracellular vesicles can carry function endothelial nitric oxide synthase (eNOS), which works in an autocrine manner to restore homeostasis following fatty acid induced oxidative stress [32] . In a similar manner, introduction of extracellular vesicles obtained from cultured cells can prevent or reverse pathological remodelling in cardiovascular tissues. Extracellular vesicles from cardiosphere-derived cells can reduce myocardial wall damage when injected into the coronary arteries of rat and pig models of acute myocardial infarction [33 && ]. The cardioprotection conferred by these extracellular vesicles is not observed when fibroblast extracellular vesicles are injected into the same models, indicating the specificity of the effect. Stem cell derived extracellular vesicles have also shown remarkable cardioprotective and regenerative potential [34] . The reparative capacity of these extracellular vesicles is likely conferred by efficient delivery of microRNAs that promote homeostatic gene expression and noninflammatory phenotypes in diseased tissue [35] . Given their natural function in delivering cargo between cells, extracellular vesicles can overcome the barriers often faced effective drug and therapeutic delivery. 
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